M&A Deal Summary |
|
|---|---|
| Date | 2025-11-24 |
| Target | Micro-Macinazione |
| Sector | Medical Products |
| Buyer(s) |
Microsize
Schedio |
| Sellers(s) | Lonza |
| Deal Type | Divestiture |
SEARCH BY
Microsize specializes in particle size reduction, powder classification, and analytical services, catering to a diverse clientele, including small biotechs, big pharma, CDMOs (API, Dosage Form, Integrated), and functional excipient companies. Microsize expertise in milling and micronization processes enables to develop and manufacture products with unique physical property challenges. Microsize was founded in 1994 and is based in Quakertown, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
Schedio designs and manufactures specialised equipment for particle engineering and high-containment systems. Schedio is based in Stabio, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1897 |
| Sector | Life Science |
| Employees | 18,000 |
| Revenue | 6.6B CHF (2024) |
Lonza is a global company that focuses on the life sciences sector, offering products and services for the pharmaceutical, biotech, and nutrition markets. Their portfolio spans across biopharmaceutical development and manufacturing, consumer health, nutrition, microbial control solutions, and custom manufacturing of specialty chemicals. Lonza was founded in 1897 and is based in Basel, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 5 of 5 |
| Country: Switzerland M&A | 2 of 2 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-05 |
MAST Platform
Bend, Oregon, United States The MAST® platform enables the gathering of more frequent samples and collection of real-time data, including product attributes in hours instead of weeks, compared to manual sampling. The average cell culture process can save more than 80 hours of labor generally required for sample collection, handling, and analysis. The MAST® platform is based in Bend, Oregon. |
Sell | - |
